You are here

Article Text

Article menu
Download PDFPDF
Poster exhibition Day 1
P13 Role of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node micro-metastasis in early-stage cervical cancer
  1. N Bizzarri1,
  2. L Pedone Anchora1,
  3. GF Zannoni2,
  4. A Santoro2,
  5. M Valente2,
  6. V Gallotta1,
  7. C Conte1,
  8. E Teodorico1,
  9. GLM Di Fiore1,
  10. V Ghirardi1,
  11. A Fagotti1,
  12. G Ferrandina1 and
  13. G Scambia1
  1. 1Gynecologic Oncology Division
  2. 2Pathology Department, Policlinico Universitario Agostino Gemelli I.R.C.C.S. Universita Cattolica Di Roma, Rome, Italy

Abstract

Introduction/Background Evidence in literature supports the accuracy of sentinel lymph node (SLN) in early-stage cervical cancer. SLN is usually analyzed through ultra-staging examination, which cannot be performed intraoperatively as it is too cumbersome and time-consuming. One-step nucleic acid amplification (OSNA) is a rapid assay able to detect cytokeratin (CK)19-mRNA in SLN and it can be used for intra-operative detection of macro-metastasis, micro-metastasis and isolated tumor cells (ITC). It consists of a short homogenization step followed by amplification of CK19-mRNA directly from the lysate. We aim to evaluate if OSNA could be used to detect micro-metastasis in patients with early cervical cancer.

Methodology Consecutive patients who underwent surgery for FIGO stage IA1 LVSI+ to IB1 between 01/2015-02/2019, and had SLN biopsy±pelvic lymphadenectomy (PLN), were included. SLN was detected with cervical injection of indocyanine-green (1.25 mg/ml) and sent intra-operatively for OSNA. OSNA result was considered: negative: <160 CK19-copies/µL; ITC 160-249 CK19-copies/µL; micro-metastasis 250-5000 CK19-copies/µL; macro-metastasis >5000 CK19-copies/µL. The first 12 OSNA cases had immunohistochemistry staining for CK19 in the primary tumour.

Results 109 patients underwent SLN biopsy: 59 (54.1%) were analyzed with H&E, 29 (26.6%) with OSNA and 21 (19.3%) with ultra-staging. 12/12 (100%) primary tumors were CK19-positive. Patients‘ characteristics are demonstrated in table 1. In the OSNA group, 5 (17.2%) patients had unilateral and 24 (82.8%) bilateral mapping. OSNA detected micro-metastasis in 7/29 (24.1%) patients. In 5/7 (71.4%) cases, systematic bilateral PLN was performed and in all these patients, SLN was the only positive node. When PLN was performed, no false negative in bilateral detection and 1/5 (20%) false negative with unilateral detection was found.

Conclusion This is one of the first series investigating the application of SLN CK19-OSNA in early-cervical cancer. OSNA is able to detect micro-metastasis in SLN. However, further cases are necessary to define the positive predictive value of this technique.

Disclosure Nothing to disclose.

Abstract P13 Table 1
Abstract P13 Table 1

Patients’ characteristics

http://dx.doi.org/10.1136/ijgc-2019-ESGO.76

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.